CNTA
Centessa Pharmaceuticals PLC ADR
NASDAQ: CNTA · HEALTHCARE · BIOTECHNOLOGY
$39.45
-0.03% today
Updated 2026-04-29
Market cap
$6.10B
P/E ratio
—
P/S ratio
406.76x
EPS (TTM)
$-1.46
Dividend yield
—
52W range
$11 – $40
Volume
3.0M
Centessa Pharmaceuticals PLC ADR (CNTA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.83M | $-10.63M | $-136.14M | $-200.55M | $-160.34M | $-142.06M | $-193.82M |
| Capital expenditures | $186000.00 | $186000.00 | $185982.00 | $1.14M | $169000.00 | $34000.00 | $371000.00 |
| Depreciation | $6000.00 | $34000.00 | $33995.00 | $131000.00 | $810000.00 | $942000.00 | — |
| Stock-based comp | $236000.00 | $336000.00 | $14.85M | $24.96M | $29.39M | $33.55M | $30.96M |
| Free cash flow | $-6.01M | $-10.82M | $-136.33M | $-201.68M | $-160.51M | $-142.09M | $-194.19M |
| Investing cash flow | $63.26M | $63.26M | $63.25M | $-931000.00 | $-127.00M | $31.27M | — |
| Financing cash flow | $9.01M | $1.36M | $660.07M | $457000.00 | $21.12M | $364.75M | — |
| Dividends paid | — | — | $660122.00 | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |